Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Justin Moore

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Infectious Disease Clinics of North America|March 20, 2025
Current Antifungals and the Developing PipelineMelissa D Johnson, W Justin Moore
Current Opinion in Infectious Diseases|September 29, 2023
A new direction for cytomegalovirus prophylaxis among transplant recipients: Benefits and nonviral outcomes of letermovir use as primary CMV prophylaxisW Justin Moore, Catherine-Audrey Boutin, Sajal Tanna
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 11, 2021
A focus on the perceived value of preceptor support by pharmacy residents and fellows during the COVID-19 pandemicW Justin Moore, Andrew J Webb, Sheila K Wang
Open Forum Infectious Diseases|June 2, 2025
A Novel and Reproducible Urinary Diagnostic Framework Reduces Health Care and Antibiotic Utilization for Urinary Tract InfectionsKendall Kling, Teresa Zembower, W Justin Moore, et al.
Idcases|August 15, 2022
Breakthrough daptomycin-, linezolid-, vancomycin-resistant <i>Enterococcus faecium</i> bacteremia during protracted daptomycin therapy: A case reportNathan B Pincus, Tejas Joshi, Samuel W M Gatesy, et al.
Clinical Pharmacokinetics|December 11, 2021
Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19Elizabeth Leung, Ryan L Crass, Sarah C J Jorgensen, et al.
Sexually Transmitted Diseases|December 1, 2022
Tecovirimat Use in Ambulatory and Hospitalized Patients With Monkeypox Virus InfectionEn-Ling Wu, Rebecca L Osborn, Christie M Bertram, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 19, 2021
Impact of COVID-19 pandemic on training of pharmacy residents and fellows: Results from a national survey of postgraduate pharmacy traineesW Justin Moore, Andrew Webb, Taylor Morrisette, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired PneumoniaNathaniel J Rhodes, Caroline C Jozefczyk, W Justin Moore, et al.
Pharmacotherapy|February 16, 2026
Oral β-Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point-Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and FluoroquinolonesAshlan J Kunz Coyne, Jeannette Bouchard, Spencer H Durham, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Infectious Disease Clinics of North America|March 20, 2025
Current Antifungals and the Developing PipelineMelissa D Johnson, W Justin Moore
Current Opinion in Infectious Diseases|September 29, 2023
A new direction for cytomegalovirus prophylaxis among transplant recipients: Benefits and nonviral outcomes of letermovir use as primary CMV prophylaxisW Justin Moore, Catherine-Audrey Boutin, Sajal Tanna
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 11, 2021
A focus on the perceived value of preceptor support by pharmacy residents and fellows during the COVID-19 pandemicW Justin Moore, Andrew J Webb, Sheila K Wang
Open Forum Infectious Diseases|June 2, 2025
A Novel and Reproducible Urinary Diagnostic Framework Reduces Health Care and Antibiotic Utilization for Urinary Tract InfectionsKendall Kling, Teresa Zembower, W Justin Moore, et al.
Idcases|August 15, 2022
Breakthrough daptomycin-, linezolid-, vancomycin-resistant <i>Enterococcus faecium</i> bacteremia during protracted daptomycin therapy: A case reportNathan B Pincus, Tejas Joshi, Samuel W M Gatesy, et al.
Clinical Pharmacokinetics|December 11, 2021
Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19Elizabeth Leung, Ryan L Crass, Sarah C J Jorgensen, et al.
Sexually Transmitted Diseases|December 1, 2022
Tecovirimat Use in Ambulatory and Hospitalized Patients With Monkeypox Virus InfectionEn-Ling Wu, Rebecca L Osborn, Christie M Bertram, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 19, 2021
Impact of COVID-19 pandemic on training of pharmacy residents and fellows: Results from a national survey of postgraduate pharmacy traineesW Justin Moore, Andrew Webb, Taylor Morrisette, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired PneumoniaNathaniel J Rhodes, Caroline C Jozefczyk, W Justin Moore, et al.
Pharmacotherapy|February 16, 2026
Oral β-Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point-Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and FluoroquinolonesAshlan J Kunz Coyne, Jeannette Bouchard, Spencer H Durham, et al.
Pageof 2